American Heart Journal
Volume 135, Issue 5 , Pages 819-824 , May 1998

Comparison of Quality of Well-Being scale and NYHA functional status classification in patients with atrial fibrillation

Received 23 April 1997 ,Accepted 17 December 1997.

References 

  1. Testa MA, Anderson RB, Nackley JF, Hollenberg NK. Quality of life and antihypertensive therapy in men. A comparison of captopril with enalapril. The Quality-of-Life Hypertension Study Group. N Engl J Med. 1993;328:907–913
  2. Spilker B, Molinek FR, Johnston KA, Simpson RL, Tilson HH. Quality of life bibliography and indexes. Med Care. 1990;28(Suppl 12):DS1–DS77
  3. The Criteria Committee of the New York Heart Association I. Diseases of the heart and blood vessels: nomenclature and criteria for diagnosis. 6th ed. Boston: Little, Brown; 1964;
  4. Selzer A, Cohn K. Functional classification of cardiac disease: a critique. Am J Cardiol. 1972;30:306–308
  5. Patterson JA, Naughton J, Pietras RJ, Gunnar RM. Treadmill exercise in assessment of the functional capacity of patients with cardiac disease. Am J Cardiol. 1972;30:757–762
  6. Franciosa JA, Ziesche S, Wilen M. Functional capacity of patients with chronic left ventricular failure. Am J Med. 1979;67:460–466
  7. Smith RF, Johnson G, Ziesche S, Bhat G, Blankenship K, Cohn JN. Functional capacity in heart failure: comparison of methods for assessment and their relation to other indexes of heart failure. Circulation. 1993;87(suppl VI):VI-88–VI-93
  8. Goldman L, Hashimoto B, Cook F, Loscalzo A. Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale. Circulation. 1981;64:1227–1234
  9. Herlitz J. Comparison of lisinopril versus digoxin for congestive heart failure during maintenance diuretic therapy. The Lisinopril-Digoxin Study Group. Am J Cardiol. 1992;70:84C–90C
  10. Dei Cas L, Metra M, Visioli O. Effects of acute and chronic ibopamine administration on resting and exercise hemodynamics, plasma catecholamines and functional capacity of patients with chronic congestive heart failure. Am J Cardiol. 1992;70:629–634
  11. Davies RF, Beanlands DS, Nadeau C, et al.  Enalapril versus digoxin in patients with congestive heart failure: a multicenter study. Canadian Enalapril Versus Digoxin Study Group. J Am Coll Cardiol. 1991;18(7):1602–1609
  12. Kleber FX, Niemoller L, Fischer M, Doering W. Influence of severity of heart failure on the efficacy of angiotensin-converting enzyme inhibition. Am J Cardiol. 1991;68:121D–126D
  13. DiBianco R. A large-scale trial of captopril for mild to moderate heart failure in the primary care setting. Clin Cardiol. 1991;14:676–682
  14. Fananapazir L, Leon MB, Bonow RO, Tracy CM, Cannon RO, Epstein SE. Sudden death during empiric amiodarone therapy in symptomatic hypertrophic cardiomyopathy. Am J Cardiol. 1991;67:169–174
  15. Gorkin L, Norvell NK, Rosen RC, et al.  Assessment of quality of life as observed from the baseline data of the Studies of Left Ventricular Dysfunction (SOLVD) trial quality-of-life substudy. Am J Cardiol. 1993;71:1069–1073
  16. Kaplan RM, Anderson JP, Ganiats TG. The quality of well-being scale: rationale for a single quality of life index. In: 2nd ed.  Walker SR,  Rosser RM editor. Quality of life assessment: key issues in the 1990s. London: MTM Press; 1993;p. 65–94
  17. Kaplan RM, Anderson JP, Wu AW, Mathews WC, Kozin F, Orenstein D. The quality of well-being scale: applications in AIDS, cystic fibrosis, and arthritis. Med Care. 1989;2(Suppl 7):S27–S43
  18. Kaplan RM, Bush JW, Berry CC. The reliability, stability and generalizability of a health status index. In:  Society AS editors. Proceedings of the social statistics section. Washington, DC: American Statistical Society; 1978;
  19. Kaplan RM, Bush JW. Health-related quality of life measurements for evaluation research and policy analysis. Health Psychol. 1982;1:61–80
  20. Ganiats T, Palinkas L, Kaplan R. Comparison of quality of well-being scale and functional status index in patients with atrial fibrillation. Med Care. 1992;30:958–964
  21. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. In: New York: Oxford University Press; 1996;p. 425
  22. SPAF Investigators . Design of multicenter randomized trial for the stroke prevention in atrial fibrillation study. Stroke. 1990;21:538–545
  23. SPAF Investigators . Warfarin compared to aspirin for prevention of arterial thromboembolism in atrial fibrillation: design and patient characteristics of the Stroke Prevention in Atrial Fibrillation II Study. Cerebrovasc Dis. 1992;2:332–341
  24. Kaplan RM, Anderson JP, Patterson TL, et al.  Validity of the quality of well-being scale for persons with human immunodeficiency virus infection. Pyschosom Med. 1995;57:138–147
  25. Kaplan RM, Atkins CJ, Timms R. Validity of a quality of well-being scale as an outcome measure in chronic obstructive pulmonary disease. J Chron Dis. 1984;37:85–95
  26. Eakin EG, Sassi-Dambron DE, Ries AL, Kaplan RM. Reliability and validity of dyspnea measures in patients with obstructive lung disease. Int J Behav Med. 1995;2:118–134

☆ From the aUniversity of California San Diego (UCSD) Department of Family and Preventive Medicine, bUCSD Health Outcomes Assessment Program, and cUCSD Department of Medicine.

☆☆ Supported by grant #R01-HS-06098 from the Agency for Health Care Policy and Research and by grant #R01-NS-24424 from the Division of Stroke and Trauma, National Institute of Neurological Disorders and Stroke.

★ Reprint requests: Theodore G. Ganiats, MD, Department of Family and Preventive Medicine, UC San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0622.

★★ 4/1/88960

PII: S0002-8703(98)70040-7

American Heart Journal
Volume 135, Issue 5 , Pages 819-824 , May 1998

Article Tools

* Image Usage & Resolution